Rationale for the Use of Azithromycin as Mycobacterium avium Chemoprophylaxis
- 26 May 1997
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 102 (5) , 37-49
- https://doi.org/10.1016/s0002-9343(97)00043-0
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Comparative activity of azithromycin against clinical isolates of mycobacteriaJournal of Antimicrobial Chemotherapy, 1996
- Rapid Development of Resistance to Clarithromycin Following Monotherapy for Disseminated Mycobacterium chelonae Infection in a Heart Transplant PatientClinical Infectious Diseases, 1995
- Lack of Acidification in Mycobacterium Phagosomes Produced by Exclusion of the Vesicular Proton-ATPaseScience, 1994
- Interference by Subinhibitory Concentrations of Azithromycin with the Mechanism of Bacterial Adhesion to Human Epithelial CellsChemotherapy, 1993
- Pharmacokinetic Drug Interactions of MacrolidesClinical Pharmacokinetics, 1992
- Inhibition of motility ofPseudomonas aeruginosa andProteus mirabilis by subinhibitory concentrations of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Influence of the test medium on azithromycin and erythromycin regression statisticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Effects of environmental factors on the in vitro potency of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- A modified broth dilution assay for antibiotic sensitivity testing of Mycobacterium avium-intracellulare using paraffin slide culturesTubercle, 1991
- In Vitro and In Vivo Activity of Azithromycin (CP 62,993) Against the Mycobacterium avium ComplexThe Journal of Infectious Diseases, 1989